Browsing by Author "Palatnik, Anna"

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Association between perceived ethnic discrimination and receipt of COVID-19 vaccine in pregnancy or postpartum
    (American Journal of Obstetrics & Gynecology, 2023) Jaeke, Elisha; Anguzu, Ronald; Greenberg, Rachel; Palatnik, Anna
    Pregnant patients receiving prenatal care at a Midwestern academic institution were approached between June 2021 and March 2022 to complete a web-based Perceived Ethnic Discrimination Questionnaire (PED-Q). The PED-Q is a validated 17-item scale measuring perceived interpersonal racial and ethnic discrimination through four domains: workspace/school domain, exclusion domain, stigma domain, and threat domain, with each domain containing questions rated on a five-point Likert scale ranging from “never” to “very often”. All four domains were summarized in a lifetime discrimination score ranging from 1 to 5. The primary outcome was receipt of COVID-19 vaccination. A multivariate logistic regression model was used to examine the association between “lifetime discrimination score” and COVID-19 vaccination in pregnancy or postpartum.
  • Thumbnail Image
    Item
    Body mass index and persistent hypertension in patients with hypertension disorders of pregnancy one-year postpartum
    (American Journal of Obstetrics & Gynecology, 2023) Anguzu, Ronald; Livergood, M Christine; Fitzgerald, Garrett; Palatnik, Anna
    This was a retrospective cohort study of patients with HDP (defined as gestational hypertension or preeclampsia) in a single US Midwestern academic institution from 2014 to 2018. The primary outcome was persistent hypertension at one-year postpartum, defined as systolic blood pressure (BP) ≥130 mm Hg or diastolic BP ≥80 mm Hg. Both categorical BMI (model 1) (normal, overweight, and obese) and continuous BMI (model 2) were examined as predictor variables. Descriptive statistics and logistic and linear regression analyses were run for categorical and continuous BMI respectively. Odds ratios (OR) and 95% confidence intervals (CI) were reported.
  • Thumbnail Image
    Item
    Contraception utilization in women with pregestational diabetes
    (The European Journal of Contraception & Reproductive Health Care, 2022) Walker, Shannon L.; Anguzu, Ronald; Egede, Leonard E.; Palatnik, Anna
    Cross-sectional data on women aged 18–44 years from 2011 to 2017 National Survey of Family Growth (NSFG) was analysed. Maternal diabetes was defined as the presence of pre-gestational type 1 or type 2 diabetes. Bivariate and multiple logistic regression analyses were run to evaluate the association between the use of contraception and by contraception type: permanent, long-acting reversible contraception (LARC), other hormonal method, other non-hormonal method, and none, and maternal diabetes status, controlling for relevant covariates. Among the total study sample of 28,454, 1344 (4.7%) had pregestational diabetes. Unadjusted analysis showed women with a history of pregestational diabetes were more likely to use permanent contraception following pregnancy (58.0% vs. 38.7%, p < 0.001) or no contraception (27.2% vs. 24.5%, p < 0.001), but less likely to use LARC (3.4% vs. 11.7%, p < 0.001), other hormonal contraception (4.1% vs. 8.9%, p < 0.001), or other non-hormonal contraception (7.2% vs. 16.4%, p < 0.001). In adjusted analyses, permanent (aOR 1.62, 95% CI 0.72–2.26) remained significant, however the differences were no longer statistically significant: LARC (aOR 0.34, 95% CI 0.12–1.00); other hormonal (aOR 0.61, 95% CI 0.27–1.35); other non-hormonal (aOR 0.59, 95% CI 0.25–1.43); and None (aOR 1.11, 95% CI 0.65–1.89). In this analysis, we found that women with pregestational diabetes were more likely to use permanent contraception methods compared to women without pregestational diabetes; however over a quarter of women with pregestational diabetes did not use contraception between pregnancies.
  • Thumbnail Image
    Item
    Prospective survey of discrimination in pregnant persons and correlation with unplanned healthcare utilization
    (American Journal of Obstetrics & Gynecology, 2023) Greenberg, Rachel; Anguzu, Ronald; Jaeke, Elisha; Palatnik, Anna
    This was a prospective cohort study of pregnant persons receiving care at a single Midwestern academic institution from 2021 to 2022. Primary data was collected from participants on sociodemographic factors and on Perceived Ethnic and Discrimination Questionnaire (PED-Q), a validated 17-item scale measuring perceived lifetime interpersonal racial and ethnic discrimination in four domains: work/school, social exclusion, stigmatization, and threat. The primary outcome was unplanned healthcare utilization, defined as unplanned labor and delivery admissions, triage, Emergency Department, or urgent care visits. Bivariate and multivariate analyses were done to examine the association between lifetime exposure to discrimination and unplanned healthcare utilization.